(±)- Trans -2-(3-methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist

References

Page 1

	Year	Citations
Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). Constantinos A. Demopoulos, R. Neal Pinckard, D J Hanahan Journal of Biological Chemistry Proteinlipid InteractionPlatelet-activating FactorRabbit PlateletsChemical BiologyCellular Physiology	1979	1.2K
Antihypertensive activity of an alkyl ether analog of phosphatidylcholine Merle L. Blank, Fred Snyder, Lawrence W. Byers, Biochemical and Biophysical Research Communications MedicinePhysiologyPharmacological AgentAlkyl Ether AnalogPharmacotherapy	1979	558
Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives B. Boris Vargaftig, Jean Lefort, Michel Chignard, European Journal of Pharmacology InflammationAsthmaThrombopoiesisInflammatory Lung DiseaseBlood Platelet	1980	415
CV-3988 - A specific antagonist of platelet activating factor (PAF) Zen‐ichi Terashita, Susumu Tsushima, YOSHIO YOSHIOKA, Life Sciences InflammationThrombosisThrombopoiesisSpecific AntagonistCardiovascular Disease	1983	336
Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J. Casals‐Stenzel, G. Muačević, K. H. Weber Journal of Pharmacology and Experimental Therapeutics	1987	268
Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. Linda M. McManus, D J Hanahan, Constantinos A. Demopoulos, The Journal of Immunology	1980	262
Potent ulcerogenic actions of platelet-activating factor on the stomach Ann-Charlotte Rosam, John L. Wallace, Brendan J.R. Whittle Nature InflammationThrombosisThrombopoiesisPotent Ulcerogenic ActionsBlood Platelet	1986	247
Specific binding of phospholipid platelet-activating factor by human platelets. Frank H. Valone, Eric Coles, V R Reinhold, The Journal of Immunology Proteinlipid InteractionLipid MovementPlatelet AggregationCellular PhysiologyThrombosis	1982	231
Specific receptor sites for 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes San Bao Hwang, Ching Shin C. Lee, Mary Jane Cheah, Biochemistry	1983	225
BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L. P. Braquet, B. Spinnewyn, M. Braquet, Blood & Vessel Molecular PharmacologyMedicinal ChemistryBiochemistryFunctional SelectivityMedicine	1985	206

Page 1